Bunka Christopher

Director | CEO

1 company

Bunka Christopher is a Director at Lexaria Bioscience Corp.. Recent SEC Form 4 filings include 12 buys and 0 sells.

Estimated insider holdings value: $145K based on current market prices.

Holdings by Company

LEXXMar 17, 2026

Current Shares273.5K

Value$145.0K

Net Activity+223.0K

Bought: 223.0KSold: 0

Showing 2 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M	SEC
Jul 30, 2025	LEXX Lexaria Bioscience Corp.	Director	Buy	27,500	$0.92	$25,241.29	+5.2%	+4.1%	-
Nov 10, 2020	LEXX Lexaria Bioscience Corp.	CEO	Buy	195,500	$0.20	$39,768.70	+0.3%	-	-